FI860711A7 - Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. - Google Patents

Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. Download PDF

Info

Publication number
FI860711A7
FI860711A7 FI860711A FI860711A FI860711A7 FI 860711 A7 FI860711 A7 FI 860711A7 FI 860711 A FI860711 A FI 860711A FI 860711 A FI860711 A FI 860711A FI 860711 A7 FI860711 A7 FI 860711A7
Authority
FI
Finland
Prior art keywords
dessa
innehaolllande
dikarboxylsyror
laekemedel
alfa
Prior art date
Application number
FI860711A
Other languages
English (en)
Finnish (fi)
Other versions
FI860711A0 (fi
Inventor
Jacob Bar-Tana
Ernst-Christian Witte
Bernd Hagenbruch
Johannes Pill
Karlheinz Stegmeier
Original Assignee
Epis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epis Sa filed Critical Epis Sa
Publication of FI860711A0 publication Critical patent/FI860711A0/fi
Publication of FI860711A7 publication Critical patent/FI860711A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/26—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings
    • C07C55/28—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/32—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/34—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI860711A 1984-06-22 1986-02-17 Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. FI860711A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843423166 DE3423166A1 (de) 1984-06-22 1984-06-22 Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
PCT/EP1985/000288 WO1986000298A1 (fr) 1984-06-22 1985-06-15 Acides alpha, omega dicarboxyliques, procede pour leur preparation et medicaments les renfermant

Publications (2)

Publication Number Publication Date
FI860711A0 FI860711A0 (fi) 1986-02-17
FI860711A7 true FI860711A7 (fi) 1986-02-17

Family

ID=6238954

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860711A FI860711A7 (fi) 1984-06-22 1986-02-17 Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.

Country Status (17)

Country Link
US (1) US4711896A (OSRAM)
EP (1) EP0185080B1 (OSRAM)
JP (1) JPH0780807B2 (OSRAM)
AU (1) AU4607185A (OSRAM)
CA (1) CA1262552A (OSRAM)
DD (1) DD240541A5 (OSRAM)
DE (2) DE3423166A1 (OSRAM)
DK (1) DK75986D0 (OSRAM)
ES (1) ES8604090A1 (OSRAM)
FI (1) FI860711A7 (OSRAM)
GR (1) GR851509B (OSRAM)
HU (1) HUT38892A (OSRAM)
IL (1) IL75549A (OSRAM)
NO (1) NO860661L (OSRAM)
PT (1) PT80681B (OSRAM)
WO (1) WO1986000298A1 (OSRAM)
ZA (1) ZA854684B (OSRAM)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
IL101708A (en) * 1992-04-28 1996-08-04 Senyorina Ltd Anti-fattening drugs comprising amino acid derivatives
US5602164A (en) * 1992-04-28 1997-02-11 Senyorina Ltd. Anti-obesity drugs
TW322493B (OSRAM) * 1994-06-27 1997-12-11 Shell Int Research
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
IL119971A (en) 1997-01-07 2003-02-12 Yissum Res Dev Co Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
IL121165A0 (en) 1997-06-26 1997-11-20 Yissum Res Dev Co Pharmaceutical compositions containing carboxylic acids and derivatives thereof
US20020037876A1 (en) * 1998-06-25 2002-03-28 Yissum Research Development Company Of Hebrew University Of Jerusalem Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
IL145712A0 (en) 1999-04-01 2002-07-25 Esperion Therapeutics Inc Ether compounds, compositions, and uses thereof
AU2002211666A1 (en) 2000-10-11 2002-04-22 Esperion Therapeutics, Inc. Sulfide and disulfide compounds and compositions for cholesterol management and related uses
IL155246A0 (en) 2000-10-11 2003-11-23 Esperion Therapeutics Inc Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US6713507B2 (en) 2000-10-11 2004-03-30 Esperion Therapeutics, Inc. Ether compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CA2425311C (en) 2000-10-11 2011-06-14 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
EP1495034A2 (en) * 2002-04-10 2005-01-12 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
BR0312426A (pt) * 2002-07-03 2005-12-06 Esperion Therapeutics Inc Composição farmacêutica, métodos para tratar, prevenir ou controlar um colesterol, dislipidemia ou distúrbio relacionado, para reduzir ou evitar um efeito adverso associado com monoterapia de pantetina e para reduzir ou evitar um efeito adverso associado com monoterapia de segundo agente ativo, e, kit
US20040048910A1 (en) * 2002-08-22 2004-03-11 Bove Susan Elizabeth Method of treating osteoarthritis
CA2513660C (en) * 2003-01-23 2012-05-08 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
US7390504B2 (en) * 2003-11-07 2008-06-24 Jj Pharma, Inc. HDL-boosting combination therapy complexes
US20050192347A1 (en) * 2003-12-23 2005-09-01 Dasseux Jean-Louis H. Urea and thiourea compounds and compositions for cholesterol management and related uses
WO2005068412A1 (en) 2003-12-24 2005-07-28 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
WO2005062718A2 (en) * 2003-12-30 2005-07-14 Syndromex Ltd. Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid
UY28953A1 (es) * 2004-06-09 2006-01-31 Avanir Pharmaceuticals Derivados heterocíclicos para el tratamiento de hiperlipidemia y enfermedades relacionadas
EP1753782A1 (en) * 2004-06-09 2007-02-21 Avanir Pharmaceuticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
WO2005123700A1 (en) * 2004-06-09 2005-12-29 Avanir Pharmaceuticals Small molecules for treatment of hypercholesterolemia and related diseases
CA2584485C (en) * 2004-10-20 2013-12-31 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
JP5368792B2 (ja) * 2005-07-29 2013-12-18 レスバーロジックス コーポレイション 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達
DK2118074T3 (en) * 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
IL181577A0 (en) * 2007-02-26 2007-07-04 Jacob Bar Tana Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
PL2167069T3 (pl) 2007-05-23 2012-04-30 Amcol International Corp Krzemiany warstwowe oddziałujące z cholesterolem oraz sposoby zmniejszania hipercholesterolemii u ssaka
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
NZ594332A (en) 2009-01-08 2013-09-27 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular disease
KR101709492B1 (ko) 2009-03-18 2017-02-23 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
DK2473605T3 (en) 2009-09-03 2018-05-28 Pfizer Vaccines Llc PCSK9-VACCINE
US8623897B2 (en) 2010-09-20 2014-01-07 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia
WO2012131504A1 (en) 2011-03-02 2012-10-04 Pfizer Inc. Pcsk9 vaccine
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
US10479752B2 (en) 2011-12-08 2019-11-19 Syndromex Ltd. Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
WO2015123291A1 (en) 2014-02-11 2015-08-20 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Pcsk9 vaccine and methods of using the same
CN107530307A (zh) 2015-03-13 2018-01-02 艾斯柏伦治疗公司 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
CN107118098B (zh) * 2016-02-25 2020-07-14 中国科学院上海药物研究所 一类脂肪酸类化合物、其制备方法及其用途
US10512624B2 (en) 2016-11-30 2019-12-24 Syndromex Ltd. Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1
EP4438114A3 (en) 2019-06-21 2024-12-25 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
EP4003314B1 (en) 2019-07-26 2024-07-10 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease
WO2022159808A2 (en) * 2021-01-25 2022-07-28 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
TW202245804A (zh) 2021-01-25 2022-12-01 美商艾斯佩維他治療學公司 官能化長鏈烴單羧酸及二羧酸及其衍生物以及其於預防或治療疾病之用途
CN115894220A (zh) * 2021-09-23 2023-04-04 中国科学院上海药物研究所 一类作用于acly的长链类化合物、其制备方法及其用途
CN115887435A (zh) * 2021-09-23 2023-04-04 博骥源(上海)生物医药有限公司 长链类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210786B (de) * 1962-12-17 1966-02-17 Shell Int Research Verfahren zur Herstellung von p-Phenylen-bis (3, 3'-isovaleriansaeure) und 3-Phenylisovalerian-saeure
GB1556660A (en) * 1975-10-07 1979-11-28 Akzo Nv Di-carboxylic acid derivatives
IL64542A0 (en) * 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0185080B1 (de) 1989-11-08
AU4607185A (en) 1986-01-24
DK75986A (da) 1986-02-18
DE3574130D1 (en) 1989-12-14
GR851509B (OSRAM) 1985-06-25
PT80681B (de) 1987-05-08
JPS61502537A (ja) 1986-11-06
ES544439A0 (es) 1986-02-01
CA1262552A (en) 1989-10-31
JPH0780807B2 (ja) 1995-08-30
US4711896A (en) 1987-12-08
ES8604090A1 (es) 1986-02-01
IL75549A (en) 1989-03-31
DD240541A5 (de) 1986-11-05
WO1986000298A1 (fr) 1986-01-16
EP0185080A1 (OSRAM) 1986-06-25
HUT38892A (en) 1986-07-28
FI860711A0 (fi) 1986-02-17
NO860661L (no) 1986-02-21
DE3423166A1 (de) 1986-01-02
IL75549A0 (en) 1985-10-31
DK75986D0 (da) 1986-02-18
PT80681A (de) 1985-07-01
ZA854684B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
FI863200A7 (fi) Kolfibriller, foerfarande foer framstaellning av desamma samt kompositioner innehaollande desamma.
FI852203A0 (fi) 7-amino-1-cyklopropyl-6, 8-dihalogen-1, 4-dihydro-4-oxo-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning samt dessa innehaollande antibakteriella aemnen.
FI853611L (fi) Bloedningshaemmande proteiner, foerfarande foer framstaellning samt deras anvaendning.
FI842110L (fi) Foerfarande foer styrning av saogblad, samt anordning foer utfoerande av foerfarandet.
FI855053A0 (fi) Foerfarande foer aostadkommande av en roerelsesignal samt mri-tomografianlaeggning foer utfoerande av naemnda foerfarande.
FI862893A0 (fi) Foerfarande foer mottagning av radiosaenda meddelanden samt mottagare foer aendamaolet.
FI860711A0 (fi) Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.
FI852965L (fi) Avskrapningsanordning samt foerfarande, daer det anvaendes foerspaennt avskrapningsbett.
FI854466L (fi) Alkyl-1-cyklopropyl-1,4-dihydro-4 -oxo-3-kinolinkarboxylsyror, foerfaranden foer framstaellning av dessa samt dessa innehaollande antibakteriella medel.
FI851736A0 (fi) Amidinohydrazoner av tetralin-, kromon-, tiokromon- och tetrahydrokinolinderivat, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI880164A0 (fi) Staolband samt av staolbandet framstaellt verktyg.
FI861257A7 (fi) Antistatiska hoegre n-alkyl- och n-alkenylneoalkanoamider, foerfarande foer framstaellning av dessa, antistatiska kompositioner innehaollande saodana amider samt foerfarande foer minskning av ackumulering av statiska laddningar i tvaett.
FI860426L (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
FI843959L (fi) Nytt foerfarande foer framstaellning av kefalosporiner, vid framstaellning av kefalosporin anvaendbar mellanprodukt samt foerfarande foer framstaellning av naemnda mellanprodukt.
FI863837L (fi) Foerfarande foer foerpackning av livsmedel, saerskilt matportioner samt medelst foerfarandet aostadkommen foerpackning.
FI841003L (fi) Foerfarande foer framstaellning av staellningar, speciellt stegar.
FI855085A7 (fi) En blandning av olika dihydropyridiner, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI861073L (fi) Foerfarande foer framstaellning av guanidiner, saosom linoglirid, samt foerfarande foer framstaellning av mellanprodukter.
FI850604A0 (fi) Anordning foer styckevis tvaermaetning av laongstraeckta foeremaol, foeretraedesvis virkesstycken.
FI853882A0 (fi) Foerfarande foer framstaellning av cellulosafiber respektive aendloesa cellulosafiber samt anordning foer utfoerande av foerfarandet.
FI852914L (fi) Fjaederkraftackumulator foer en av lasten beroende samt fjaerrstyrd frigoering av en dornfoersedd lastmottagande anordning.
FI841632A0 (fi) Foerfarande foer framstaellning av laett instaellbara, haollbara anod- och jaernfoerelseelektrodkomponenter foer katod katodiskt skydd.
FI840835A7 (fi) Foerfarande foer tillverkning av en ihaolig traestaong, anordning foer tillaempning av foerfarandet samt en med foerfarandet aostadkommen ihaolig traestaong.
FI852934A0 (fi) Foerfarande foer montering av lagerlamellen i kamrullen i en hydraulmotors kolv, lageranordning foer kamrulle samt en lagerlamell.
FI843407L (fi) Foerfarande foer byktorkning samt anordning foer genomfoerande av densamma.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: EPIS S.A.